| Pronunciation |
 (oh
LOP ah tah
deen) |
 |
| U.S. Brand Names |
| Patanol® |
|
| Generic Available |
|
No |
|
| Pharmacological Index |
|
Antihistamine; Ophthalmic Agent, Miscellaneous |
|
| Use |
|
Treatment of the signs and symptoms of allergic conjunctivitis |
|
| Pregnancy Risk Factor |
|
C |
|
| Adverse Reactions |
|
>5%: Central nervous system: Headache (7%) <5%: Central nervous system: Weakness, cold syndrome Gastrointestinal: Taste perversion Ocular: Burning, stinging, dry eyes, foreign body sensation, hyperemia, keratitis, eyelid edema, itching Respiratory: Pharyngitis, rhinitis, sinusitis |
|
| Drug Interactions |
|
Studies evaluating drug interactions with olopatadine hydrochloride have not been conducted |
|
| Usual Dosage |
|
Adults: Ophthalmic: 1 to 2 drops in affected eye(s) twice daily every 6 to 8 hours; results from an environmental study demonstrated that olopatadine was effective when dosed twice daily for up to 6 weeks |
|
| Mental Health: Effects on Mental Status |
|
None reported |
|
| Mental Health: Effects on Psychiatric Treatment |
|
None reported |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Dosage Forms |
|
Solution, ophthalmic: 0.1% (5 mL) |
|
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
